[ARS] PFIZER INC SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

ARS

Rhea-AI Filing Summary

Analyzing...

03/12/2026 - 09:19 AM

ARS - PFIZER INC

ARS Filing - PFIZER INC

This filing is available as a PDF document.

Filing Type: ARS

Company: PFIZER INC (PFE)

Acceptance Date: 2026-03-12T09:19:45.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Pfizer

NYSE:PFE

View PFE Stock Overview →

PFE Rankings

#90 Ranked by Market Cap

#407 Ranked by Dividends

#1033 52-Week Gainer

#563 YTD Gainer

#344 Monthly Gainer

#325 Ranked by Short %Change

PFE Latest News

Mar 17, 2026

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Mar 9, 2026

Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Mar 4, 2026

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

Feb 27, 2026

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

Feb 25, 2026

ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing

PFE Latest SEC Filings

Mar 16, 2026

[Form 4] PFIZER INC Insider Trading Activity

Mar 12, 2026

[DEF 14A] PFIZER INC Definitive Proxy Statement

Mar 5, 2026

[Form 4] PFIZER INC Insider Trading Activity

Mar 5, 2026

[Form 4] PFIZER INC Insider Trading Activity

Mar 5, 2026

[Form 4] PFIZER INC Insider Trading Activity

PFE Stock Data

Market Cap 151.31B

Float 5.68B

Industry Drug Manufacturers - General

Sector Pharmaceutical Preparations

Website Link

Country United States

City NEW YORK